alexa Acute Kidney Injury in Rectal Cancer-Associated Minimal Change Disease: A Case Report | Open Access Journals
ISSN: 2161-0959
Journal of Nephrology & Therapeutics
Like us on:
Make the best use of Scientific Research and information from our 700+ peer reviewed, Open Access Journals that operates with the help of 50,000+ Editorial Board Members and esteemed reviewers and 1000+ Scientific associations in Medical, Clinical, Pharmaceutical, Engineering, Technology and Management Fields.
Meet Inspiring Speakers and Experts at our 3000+ Global Conferenceseries Events with over 600+ Conferences, 1200+ Symposiums and 1200+ Workshops on
Medical, Pharma, Engineering, Science, Technology and Business

Acute Kidney Injury in Rectal Cancer-Associated Minimal Change Disease: A Case Report

Wonngarm Kittanamongkolchai1, Wisit Cheungpasitporn1* and William W. LeCates2

1Department of Internal Medicine, Bassett Medical Center, Cooperstown, New York 13326, USA

2Department of Internal Medicine, Division of Nephrology, Bassett Medical Center and Columbia University College of Physicians and Surgeons, Cooperstown, New York 13326, USA

*Corresponding Author:
Wisit Cheungpasitporn
Department of Internal Medicine
Bassett Medical Center, Cooperstown
New York 13326, USA
E-mail: [email protected]

Received Date: March 26, 2012; Accepted Date: April 10, 2012; Published Date: April 11, 2012

Citation: Kittanamongkolchai W, Cheungpasitporn W, LeCates WW (2012) Acute Kidney Injury in Rectal Cancer-Associated Minimal Change Disease: A Case Report. J Nephrol Therapeutic 2:119. doi:10.4172/2161-0959.1000119

Copyright: © 2012 Kittanamongkolchai W, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Visit for more related articles at Journal of Nephrology & Therapeutics

Keywords

Acute kidney injury; Minimal Change Disease; Rectal Cancer

Introduction

Minimal change disease (MCD) is a major cause of nephrotic syndrome in both children and adults [1]. The characteristic histologic lesion in MCD is diffuse effacement of the epithelial foot processes on electron microscopy [2]. Most cases of MCD are idiopathic, however there have been causes of secondary MCD identified, including medications, immunizations, neoplasm, and infection. 18 percents of adults with MCD are observed to have acute kidney injury [3].

Case Presentation

A 75-year-old Caucasian man with chronic stable angina, hypertension and hypothyroidism presented to Emergency Department (ED) with shortness of breath and increased bilateral lower extremity edema for 3 weeks. His home medications included aspirin, diltiazem, levothyroxine, rosuvastatin, and ranitidine. He was found to have nephrotic syndrome with a serum albumin of 1 g/dL and a 24-hour urine protein excretion of 14 g. Microscopic urinalysis demonstrated 10-20 white blood cells/hpf and scant red blood cells. The serum creatinine had increased to 2.0 mg/dL from a baseline of 1.0 mg/dL within 1 month. Immunologic tests were negative, except for the presence of antinuclear antibodies (1:320) but without anti- DNA antibodies. Ultrasonography revealed normal sized kidneys with normal parenchymal thickness and echogenicity bilaterally.

Based on the initial presentation with shortness of breath and tachycardia, the patient was empirically treated with intravenous heparin infusion for suspected pulmonary embolism. The patient developed bleeding per rectum. Heparin was discontinued. A ventilation/perfusion (V/Q) scan showed low probability pulmonary embolism. A colonoscopy revealed a 6-cm rectosigmoid mass (Figure 1) with biopsy showing moderately differentiated adenocarcinoma. The diagnosis of adenocarcinoma of the rectosigmoid colon stage IIA was made.

nephrology-therapeutics-colonoscopy-rectosigmoid-mass

Figure 1: A colonoscopy revealed a 6 cm rectosigmoid mass.

A CT-guided percutaneous renal biopsy was performed. Findings showed normal glomeruli on light microscopy. Electron microscopy showed 100% foot process effacement, consistent with minimal change disease (MCD) (Figure 2A-b). Treatment was initiated with prednisone 80 mg daily (1 mg/kg/d) and furosemide 40 mg twice daily orally. Adenocarcinoma treatment was initiated with 5-fluorouracil (5-FU) and radiotherapy. The patient subsequently underwent a low anterior resection with loop ileostomy and was planned for 6 months of adjuvant Folfox combination chemotherapy (5-FU, leucovorin, and oxaliplatin). Lower extremity edema was improved greatly over one month. At a 4 month follow-up visit, the patient continued to do well. Serum albumin was increased to 2.6 g/dL. Urine protein to creatinine ratio was 0.3. The serum creatinine returned to 1.0 mg/dL at baseline. Prednisone had been gradually tapered to 5 mg/day.

nephrology-therapeutics-microscopy-normocellular-glomerulus

Figure 2a: A Light Microscopy revealed normocellular glomerulus.

nephrology-therapeutics-microscopy-effacement-minimal

Figure 2b: Electron microscopy showed 100% foot process effacement, consistent with minimal change disease (MCD).

Discussion

Paraneoplastic glomerular disease is a rare manifestation of malignancy that is frequently mistaken from other glomerular diseases. Failure to identify paraneoplastic glomerular disease can subject patients to ineffective therapy and delay cancer diagnosis. In patients with nephrotic syndrome, especially elderly, the possibility of underlying malignancy should be considered. Approximately 10% of nephrotic syndromes in adults are associated with malignant tumors [4].

Case reports and literature reviews have shown an association between MCD and malignancies, particularly hematologic malignancies, such as Hodgkin’s disease, non-Hodgkin lymphomas, or leukemias [5-7]. Conversely, MN has been more commonly linked with solid tumors [8]. Rare cases of MCD associated with solid tumors, including renal cell carcinoma, mesothelioma, and bronchogenic, colon, bladder, lung, breast, pancreatic, duodenal, and prostate cancer, have been reported [9].

Colorectal cancer-associated MCD is uncommon and has been reported in only 6 cases to date [10]. We present another case of rectal cancer-associated MCD with acute kidney injury and nephrotic syndrome. Vascular endothelial growth factor (VEGF) is one potential candidate for the pathogenesis of paraneoplastic MCD. Taniguchi et al. [11] reported a case with rectal adenocarcinoma associated with MCD. The VEGF level was elevated at the time of presentation. After tumor resection, proteinuria disappeared and VEGF levels decreased to normal. Whether MCD is indeed a consequence of VEGF overexpression in cancer cells remains to be determined [12].

Considering that MCD is more steroid responsive than other nephrotic diseases, early recognition and diagnosis may help to expedite effective therapy. Also, ablation of the tumor frequently results in remission of MCD [12].

References

Select your language of interest to view the total content in your interested language
Post your comment

Share This Article

Relevant Topics

Recommended Conferences

  • 15th International Conference on Nephrology & Therapeutics
    August 28-30, 2017 Philadelphia, USA
  • 16th European Nephrology Conference
    October 02-04, 2017 Barcelona, Spain
  • 16th European Nephrology Conference
    October 02-04, 2017 Barcelona, Spain
  • World Nephrology Congress
    Osaka, Japan Oct 09-11, 2017
  • 13th World Nephrology Conference
    October 18-19, 2017 Dubai,UAE
  • 16th International Conference on Nephrology
    NOVEMBER 02-03, 2017 Atlanta, USA

Article Usage

  • Total views: 11731
  • [From(publication date):
    July-2012 - Aug 23, 2017]
  • Breakdown by view type
  • HTML page views : 7961
  • PDF downloads :3770
 

Post your comment

captcha   Reload  Can't read the image? click here to refresh

Peer Reviewed Journals
 
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
 
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

 
© 2008-2017 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version
adwords